Floatz logo

Solu-Cortef

Apomorphine-induced Skin Reactions

University Medical Center GroningenPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Apomorphine-induced Skin Reactions cohort.

Asset / SponsorPhaseRating
Ginkgo Biloba Extract
Dongzhimen Hospital, Beijing
Phase 4BB
Qinggongshoutao Bolus
Dongzhimen Hospital, Beijing
Phase 4BB
Thalidomide
Chang Gung Memorial Hospital
Phase 2B
(1-(2-tetrahydrofuryl)-5-fluorouracil) and uracil 1:4
Chang Gung Memorial Hospital
Phase 2B
LAMOTRIGINE
Seoul National University Hospital
Phase 2CCC

View all 17 →

Same molecule, other indications

Solu-Cortef is also rated in:

congenital adrenal hyperplasiaDormant
A
Indicative ·
81 / 100
View asset →
childhood acute lymphoblastic leukemiaDormant
BB
Indicative ·
68 / 100
View asset →
myelodysplastic syndromeDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →